DrugPatentWatch Database Preview
Drugs in Development Information for Phenylacetic acid
Email this page to a colleague
» See Plans and PricingWhat is the drug development status for Phenylacetic acid?
Phenylacetic acid is an investigational drug.
There have been 4 clinical trials for Phenylacetic acid.
The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2017.
The most common disease conditions in clinical trials are Urea Cycle Disorders, Inborn, Disease, and Drug-Related Side Effects and Adverse Reactions. The leading clinical trial sponsors are Shijiazhuang Yiling Pharmaceutical Co. Ltd, Horizon Therapeutics, LLC, and Yiling Pharmaceutical Inc.
There are three US patents protecting this investigational drug and forty-three international patents.
Summary for Phenylacetic acid
| US Patents | 3,043 |
| International Patents | 43,172 |
| US Patent Applications | 3,816 |
| WIPO Patent Applications | 1,931 |
| Japanese Patent Applications | 11 |
| Clinical Trial Progress | Phase 1 (2017-11-01) |
| Vendors | 49 |
Recent Clinical Trials for Phenylacetic acid
| Title | Sponsor | Phase |
|---|---|---|
| A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China | Shijiazhuang Yiling Pharmaceutical Co. Ltd | Phase 1 |
| Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders | Horizon Therapeutics, LLC | Phase 4 |
| A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China | Yiling Pharmaceutical Inc. | Phase 1 |
Clinical Trial Summary for Phenylacetic acid
Top disease conditions for Phenylacetic acid
Top clinical trial sponsors for Phenylacetic acid
US Patents for Phenylacetic acid
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Phenylacetic acid | Start Trial | Compounds for the treatment of infectious diseases | Hoffmann-La Roche Inc. (Little Falls, NJ) | Start Trial |
| Phenylacetic acid | Start Trial | 4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists | Bristol-Myers Squibb Company (Princeton, NJ) | Start Trial |
| Phenylacetic acid | Start Trial | Compositions containing polymeric, ionic compounds comprising imidazolium groups | BASF SE (Ludwigshafen, DE) | Start Trial |
| Phenylacetic acid | Start Trial | Uracil derivatives as AXL and c-MET kinase inhibitors | IGNYTA, INC. (San Diego, CA) | Start Trial |
| Phenylacetic acid | Start Trial | Pyrrolidine amide compounds as histone demethylase inhibitors | GENENTECH, INC. (South San Francisco, CA) CONSTELLATION PHARMACEUTICALS INC. (Cambridge, MA) | Start Trial |
| Phenylacetic acid | Start Trial | Production of organic materials using oxidative hydrothermal dissolution method | SOUTHERN ILLINOIS UNIVERSITY CARBONDALE (Carbondale, IL) | Start Trial |
| Phenylacetic acid | Start Trial | Therapeutic inhibitory compounds | LIFESCI PHARMACEUTICALS, INC. (St. Michael, BB) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Phenylacetic acid
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Phenylacetic acid | China | 107001386 | 2034-10-11 | Start Trial |
| Phenylacetic acid | European Patent Office | 3204392 | 2034-10-11 | Start Trial |
| Phenylacetic acid | Japan | 2017531655 | 2034-10-11 | Start Trial |
| Phenylacetic acid | World Intellectual Property Organization (WIPO) | 2016055553 | 2034-10-11 | Start Trial |
| Phenylacetic acid | Argentina | 104884 | 2035-06-03 | Start Trial |
| Phenylacetic acid | Australia | 2016270903 | 2035-06-03 | Start Trial |
| Phenylacetic acid | Brazil | 112017024846 | 2035-06-03 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
